More tools:Markets·Screener·Research·Chat

BioCardia, Inc. Common Stock (BCDA) Financial Statements

BioCardia, Inc. Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001S72MS0
XNAS · usd
1.11▼ 0.00 (-0.35%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close1.11
Day's Range1.08 – 1.14
52-Week Range0.75 – 2.29
Volume130.2K
Avg Volume213.5K
Share Statistics
Shares Outstanding
Employees21
ExchangeXNAS
Listed1995-10-25
Share count as of August 11, 2026
Loading Income Statement…
Key questions about BioCardia, Inc. Common Stock (BCDA)
What is BioCardia, Inc. Common Stock's Market Cap?
BioCardia, Inc. Common Stock's Market Cap is $16.7M, based on as-reported figures from SEC (XBRL) filings.
What is BioCardia, Inc. Common Stock's Enterprise Value?
BioCardia, Inc. Common Stock's Enterprise Value is $12.6M, based on as-reported figures from SEC (XBRL) filings.
What is BioCardia, Inc. Common Stock's EV / EBITDA?
BioCardia, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is BioCardia, Inc. Common Stock's Revenue (TTM)?
BioCardia, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is BioCardia, Inc. Common Stock's Net Income (TTM)?
BioCardia, Inc. Common Stock's Net Income (TTM) is -$7.3M, based on as-reported figures from SEC (XBRL) filings.
What is BioCardia, Inc. Common Stock's EBITDA?
BioCardia, Inc. Common Stock's EBITDA is -$7.4M, based on as-reported figures from SEC (XBRL) filings.
What is BioCardia, Inc. Common Stock's Diluted EPS (TTM)?
BioCardia, Inc. Common Stock's Diluted EPS (TTM) is -0.48, based on as-reported figures from SEC (XBRL) filings.
What is BioCardia, Inc. Common Stock's Net Debt?
BioCardia, Inc. Common Stock's Net Debt is -$4.1M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Costs and expenses:
Research and development
Selling, general and administrative
Total costs and expenses
Operating loss
Other income (expense):
Total other income, net
Net loss
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)